Attached files

file filename
10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc.ebig_10k.htm
EX-31.2 - CERTIFICATION - Cellular Biomedicine Group, Inc.ebig_ex312.htm
EX-31.1 - CERTIFICATION - Cellular Biomedicine Group, Inc.ebig_ex311.htm
EX-10.22 - COMPASS ACQUISITION CORP. - Cellular Biomedicine Group, Inc.ebig_ex1022.htm
Exhibit 32

Section 1350 Certifications
 
Pursuant to 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of EastBridge Investment Group Corporation, an Arizona corporation (the Company), hereby certify that:
 
To my knowledge, the Annual Report on Form 10-K of the Company for the annual period ended December 31, 2010 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated:  April 13, 2011
       
 
By:
/s/ Keith Wong  
   
Keith Wong
 
   
Chief Executive Officer
 
 
Dated:  April 13, 2011
       
 
By:
/s/ Norm Klein  
   
Norm Klein
 
   
Principal Financial and Accounting Officer